cronos group glp-1 receptor agonist weight management diabetes treatments agonists are increasingly used to treat type 2 and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal GLP1 Receptor Agonists—Effects beyond Obesity

Learn why experts say it's a "real-time experiment" you shouldn't risk.

Explore whether the wide health benefits of GLP1 drugssuch as blood sugar control, weight loss, heart and brain protection.

The results of the PIONEER-3 trial have now been published in the renowned journal Journal of the American Medical Association (JAMA) and are said to be trend-setting for future therapy of type 2 diabetes.

REDUCE HUNGER & CRAVINGS: Patented and clinically-studied Supresa saffron extract is shown to reduce hunger and snacking in as early as 8 weeks in clinical study participants. SUPPORT WEIGHT MANAGEMENT: Clinically-tested Morosil red orange extract is shown to support fat reduction, reduce BMI and combat visceral fat (in combination with diet and exercise) in clinical study participants. The product is formulated to support healthy weight management

By promoting GLP-1 support, it helps encourage a feeling of fullness, acts as a natural appetite suppressant, and promotes weight loss management when taken before meals

Alex Zhavoronkov, discussed how the GLP-1 revolution is expanding beyond weight loss toward healthy longevity